CHU Rouen, Hopital Charles Nicolle

Rouen 76031

0 studies enrolling now · 8 studies all time

What they study most

Acute Coronary Syndrome, Alopecia Areata, Atrial Fibrillation, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Dysmotility, Heart Failure With Preserved Ejection Fraction, Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease, Ischemic Stroke; Ischemic Attack, Transient

Studies at this site

• Premedication to Reduce Amivantamab Associated Infusion Related Reactions — Running, not enrolling
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease — Completed
• A Long Term Study to Find Out if Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease — Stopped early
• A Study of JNJ-64304500 in Participants With Alopecia Areata — Withdrawn before enrolling
• Ulimorelin Study of Efficacy and Safety (ULISES 008) — Completed